Patents by Inventor Tae Lim Kim

Tae Lim Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11355006
    Abstract: Disclosed is a crosswalk system according to various embodiments comprising an infrastructure including a communication device, a vehicle communicating with the infrastructure, and an indicating device electrically connected to the infrastructure. The infrastructure may detect an external object within a predetermined area through at least one sensor, obtain a location of the vehicle through the communication device, and based on the detected external object and the obtained position of the vehicle, transmit to the indicating device a signal requesting provision of information related to whether it is possible to cross the predetermined area from the external object or the vehicle. Other various embodiment may be implemented.
    Type: Grant
    Filed: August 12, 2021
    Date of Patent: June 7, 2022
    Assignee: KOREA AUTOMOTIVE TECHNOLOGY INSTITUTE
    Inventors: Hyun Woo Cho, Ho Joon Kang, Tae Lim Kim, Seong-Jin Kwon, Seok-San Shin, Ju Yeon Hwang
  • Patent number: 9758571
    Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus radiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: September 12, 2017
    Assignees: University—Industry Cooperation Group Of Kyung Hee University, Myongji University Industry and Academia Cooperation Foundation
    Inventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
  • Patent number: 9580479
    Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus <i/> radiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: February 28, 2017
    Assignees: University—Industry Cooperation Group of Kyung Hee University, Myongji University Industry and Academia Cooperation Foundation
    Inventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
  • Publication number: 20150191532
    Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcusradiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.
    Type: Application
    Filed: June 20, 2013
    Publication date: July 9, 2015
    Applicant: Myongi University Industry and Academai Cooperatio Foundation
    Inventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
  • Publication number: 20150175669
    Abstract: There are provided peptide tags derived from bacteriophytochrome (BphP) that is photoreceptor protein of Deinococcus <i/> radiodurans, an antibody capable of specifically recognizing the peptide tags, hybridoma cell lines capable of producing the antibody, and uses thereof. The novel peptide tag has advantages in that it has a short length and can remove a non-specific reaction of the conventional c-myc tag and FLAG tag. Therefore, in the case of using the novel peptide tag and antibody thereto, the fusion protein expressed in a recombinant cell can be very effectively detected or purified. In addition, an epitope tagging system including the novel peptide tag and antibody thereto can be applied in various fields such as a determination of an intracellular site, a confirmation of functionality, detection and purification of specific protein, and researches on interaction between proteins.
    Type: Application
    Filed: June 20, 2013
    Publication date: June 25, 2015
    Applicant: University- Industry Cooperation Group of Kyung Hee University
    Inventors: Seong Hee Bhoo, Tae Ryong Hahn, Tae Lim Kim, Joo Won Suh, Seung Hwan Yang
  • Patent number: 8343940
    Abstract: Disclosed herein is a method for enhancing sensitivity of cancer cells to compounds or radiation by inhibiting the expression of testis-specific protein, Y-encoded like 5 (TSPYL5). More specifically, because methylation of TSPYL5 protein expressed in lung cancer cell line was inhibited to increase the expression level of the gene, resistance to stress such as radiation or anticancer agents was increased. Because the sensitivity of cancer cells to stress such as radiation or anticancer agents was increased by inhibiting the expression of the TSPYL5 gene to promote the apoptosis of the cells, an anticancer supplement agent containing an inhibitor of the expression or activity of the TSPYL5 gene of the present invention inhibits the growth of cancer cells and enhances the sensitivity to various stresses to maximize the apoptosis. Thus, when used in combination with radiotherapy or chemotherapy, the anticancer supplement agent may be used very usefully for anticancer treatment.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: January 1, 2013
    Assignee: Korea Atomic Energy Research Institute
    Inventors: In Gyu Kim, Tae Lim Kim, Kug Chan Kim, Eun Jin Kim, So Yong Lee, Il Lae Jung
  • Publication number: 20110111400
    Abstract: Disclosed herein is a method for enhancing sensitivity of cancer cells to compounds or radiation by inhibiting the expression of testis-specific protein, Y-encoded like 5 (TSPYL5). More specifically, because methylation of TSPYL5 protein expressed in lung cancer cell line was inhibited to increase the expression level of the gene, resistance to stress such as radiation or anticancer agents was increased. Because the sensitivity of cancer cells to stress such as radiation or anticancer agents was increased by inhibiting the expression of the TSPYL5 gene to promote the apoptosis of the cells, an anticancer supplement agent containing an inhibitor of the expression or activity of the TSPYL5 gene of the present invention inhibits the growth of cancer cells and enhances the sensitivity to various stresses to maximize the apoptosis. Thus, when used in combination with radiotherapy or chemotherapy, the anticancer supplement agent may be used very usefully for anticancer treatment.
    Type: Application
    Filed: June 24, 2010
    Publication date: May 12, 2011
    Applicant: Korea Atomic Energy Research Institute
    Inventors: In Gyu KIM, Tae Lim Kim, Kug Chan Kim, Eun Jin Kim, So Yong Lee, Il Lae Jung